Why NeoGenomics (NEO) Stock Is Surging Today

NEW YORK (TheStreet) -- Craig-Hallum set a "buy" rating on NeoGenomics  (NEO) and increased its price target on the stock to $8 from $5. 

The stock was up 12.12% to $4.07 at 3:08 p.m. More than 1 million shares had changed hands, compared to the average volume of 270,889.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

NEO Price Chart

NEO Price data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

If you liked this article you might like

The Most Admired Corporate Dealmakers in a Record Year

The Most Admired Corporate Dealmakers in a Record Year

Everybody's Doing It: 5 Stocks Under $10 That I Like

Everybody's Doing It: 5 Stocks Under $10 That I Like

Lock Down Gains in Big Winners

Lock Down Gains in Big Winners

NeoGenomics Deal With GE's Clarient 6 Months Later: Boom or Bust?

NeoGenomics Deal With GE's Clarient 6 Months Later: Boom or Bust?

Yellen's Words of Warning Don't Faze Market

Yellen's Words of Warning Don't Faze Market